Functional consequences of S1P receptor modulation in rat oligodendroglial lineage cells

No abstract is available for this paper.

• Publication year

  2007

• Venue

  Glia

• Publication date

  2007-12-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1002/glia.20576PMID 17876806
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Activation of sphingosine‐1‐phosphate receptor S1P5 inhibits oligodendrocyte progenitor migration

  2007influential reference
• Mapping Pathways Downstream of Sphingosine 1-Phosphate Subtype 1 by Differential Chemical Perturbation and Proteomics*

  2007cited by this paper
• Immunosuppressive and Anti-angiogenic Sphingosine 1-Phosphate Receptor-1 Agonists Induce Ubiquitinylation and Proteasomal Degradation of the Receptor*

  2007cited by this paper
• CNS mediated effects of FTY720 (Fingolimod) in EAE

  2007influential reference
• Sphingosine kinase type 2 is essential for lymphopenia induced by the immunomodulatory drug FTY720.

  2006cited by this paper
• Cdc42 and Rac1 Signaling Are Both Required for and Act Synergistically in the Correct Formation of Myelin Sheaths in the CNS

  2006influential reference
• Insulin-like Growth Factors Mediate Heterotrimeric G Protein-dependent ERK1/2 Activation by Transactivating Sphingosine 1-Phosphate Receptors*

  2006cited by this paper
• Oral fingolimod (FTY720) for relapsing multiple sclerosis.

  2006cited by this paper
• Sphingosine‐1‐phosphate is released by cerebellar astrocytes in response to bFGF and induces astrocyte proliferation through Gi‐protein‐coupled receptors

  2006cited by this paper
• Edg8/S1P5: An Oligodendroglial Receptor with Dual Function on Process Retraction and Cell Survival

  2005influential reference
• PDGF α-Receptor Signal Strength Controls an RTK Rheostat That Integrates Phosphoinositol 3′-Kinase and Phospholipase Cγ Pathways during Oligodendrocyte Maturation

  2005cited by this paper
• S1P1-selective in vivo-active agonists from high-throughput screening: off-the-shelf chemical probes of receptor interactions, signaling, and fate.

  2005cited by this paper
• Myelin repair: developmental myelination redux?

  2005cited by this paper
• Novel role of sphingosine kinase 1 as a mediator of neurotrophin‐3 action in oligodendrocyte progenitors

  2005cited by this paper
• Glial cell line‐derived neurotrophic factor‐induced signaling in Schwann cells

  2005cited by this paper
• Sphingosine Kinase 2 Is Required for Modulation of Lymphocyte Traffic by FTY720*

  2005cited by this paper
• The S1P2 Receptor Negatively Regulates Platelet-Derived Growth Factor-Induced Motility and Proliferation

  2005cited by this paper
• Sphingosine 1-Phosphate Receptors Regulate Chemokine-Driven Transendothelial Migration of Lymph Node but Not Splenic T Cells1

  2005cited by this paper
• PDGF alpha-receptor signal strength controls an RTK rheostat that integrates phosphoinositol 3'-kinase and phospholipase Cgamma pathways during oligodendrocyte maturation.

  2005cited by this paper
• Sphingosine 1-phosphate receptor agonists attenuate relapsing-remitting experimental autoimmune encephalitis in SJL mice.

  2004cited by this paper
• IGF‐I prevents glutamate‐mediated bax translocation and cytochrome C release in O4+ oligodendrocyte progenitors

  2004cited by this paper
• Differential transactivation of sphingosine-1-phosphate receptors modulates NGF-induced neurite extension

  2004influential reference
• Sphingosine 1-phosphate transactivates the platelet-derived growth factor beta receptor and epidermal growth factor receptor in vascular smooth muscle cells.

  2004cited by this paper
• S1P and LPA trigger Schwann cell actin changes and migration

  2004cited by this paper
• Rho Kinase Regulates Schwann Cell Myelination and Formation of Associated Axonal Domains

  2004cited by this paper
• The immunosuppressant FTY720 down‐regulates sphingosine 1‐phosphate G protein‐coupled receptors

  2004cited by this paper
• Sphingosine 1-Phosphate Transactivates the Platelet-Derived Growth Factor β Receptor and Epidermal Growth Factor Receptor in Vascular Smooth Muscle Cells

  2004cited by this paper
• Mice Deficient in Sphingosine Kinase 1 Are Rendered Lymphopenic by FTY720*

  2004cited by this paper
• Characterization of lysophosphatidic acid and sphingosine‐1‐phosphate‐mediated signal transduction in rat cortical oligodendrocytes

  2004influential reference
• Sphingosine‐1‐phosphate induces proliferation and morphological changes of neural progenitor cells

  2004cited by this paper
• Lysophospholipid G Protein-coupled Receptors*

  2004cited by this paper
• Lymphocyte egress from thymus and peripheral lymphoid organs is dependent on S1P receptor 1

  2004cited by this paper
• Blood Lipid Mediator Sphingosine 1-Phosphate Potently Stimulates Platelet-derived Growth Factor-A and -B Chain Expression through S1P1-Gi-Ras-MAPK-dependent Induction of Krüppel-like Factor 5*

  2004cited by this paper
• Amelioration of Experimental Autoimmune Encephalomyelitis in Lewis Rats by FTY720 Treatment

  2003cited by this paper
• Sphingosine 1‐phosphate induces the production of glial cell line‐derived neurotrophic factor and cellular proliferation in astrocytes

  2003influential reference
• Sphingosine 1-Phosphate and Platelet-derived Growth Factor (PDGF) Act via PDGFβ Receptor-Sphingosine 1-Phosphate Receptor Complexes in Airway Smooth Muscle Cells*

  2003cited by this paper
• Phosphorylation of the Immunomodulatory Drug FTY720 by Sphingosine Kinases*

  2003cited by this paper
• PDGF upregulates delayed rectifier via Src family kinases and sphingosine kinase in oligodendroglial progenitors.

  2003influential reference
• Edg-8 receptors are preferentially expressed in oligodendrocyte lineage cells of the rat CNS.

  2003cited by this paper
• G-protein-coupled receptor S1P1 acts within endothelial cells to regulate vascular maturation.

  2003cited by this paper
• The Immune Modulator FTY720 Targets Sphingosine 1-Phosphate Receptors*

  2002influential reference
• Embryonic brain expression analysis of lysophospholipid receptor genes suggests roles for s1p1 in neurogenesis and s1p1–3 in angiogenesis

  2002cited by this paper
• Alteration of Lymphocyte Trafficking by Sphingosine-1-Phosphate Receptor Agonists

  2002cited by this paper
• Why does remyelination fail in multiple sclerosis?

  2002cited by this paper
• Marked Perinatal Lethality and Cellular Signaling Deficits in Mice Null for the Two Sphingosine 1-Phosphate (S1P) Receptors, S1P2/LPB2/EDG-5 and S1P3/LPB3/EDG-3*

  2002cited by this paper
• Sphingosine‐1‐phosphate induces proliferation of astrocytes: regulation by intracellular signalling cascades

  2001cited by this paper
• EDG‐1 links the PDGF receptor to Src and focal adhesion kinase activation leading to lamellipodia formation and cell migration

  2001influential reference
• RhoA Inhibits the Nerve Growth Factor-induced Rac1 Activation through Rho-associated Kinase-dependent Pathway*

  2001cited by this paper
• Nrg-1 Belongs to the Endothelial Differentiation Gene Family of G Protein-coupled Sphingosine-1-phosphate Receptors*

  2001cited by this paper
• FTY720 Immunosuppression Impairs Effector T Cell Peripheral Homing Without Affecting Induction, Expansion, and Memory1

  2000cited by this paper
• Inhibitory Regulation of Rac Activation, Membrane Ruffling, and Cell Migration by the G Protein-Coupled Sphingosine-1-Phosphate Receptor EDG5 but Not EDG1 or EDG3

  2000influential reference
• PDGF and FGF-2 signaling in oligodendrocyte progenitor cells: regulation of proliferation and differentiation by multiple intracellular signaling pathways.

  2000cited by this paper
• Edg-1, the G protein-coupled receptor for sphingosine-1-phosphate, is essential for vascular maturation.

  2000cited by this paper
• Nerve Growth Factor Protects Oligodendrocytes from Tumor Necrosis Factor-α-induced Injury through Akt-mediated Signaling Mechanisms*

  2000cited by this paper
• Characterization of a Novel Sphingosine 1-Phosphate Receptor, Edg-8*

  2000cited by this paper
• Cell cycle control of PDGF‐induced Ca2+ signaling through modulation of sphingolipid metabolism

  1999cited by this paper
• The novel sphingosine 1-phosphate receptor AGR16 is coupled via pertussis toxin-sensitive and -insensitive G-proteins to multiple signalling pathways.

  1999cited by this paper
• Comparison of Intrinsic Activities of the Putative Sphingosine 1-Phosphate Receptor Subtypes to Regulate Several Signaling Pathways in Their cDNA-transfected Chinese Hamster Ovary Cells*

  1999cited by this paper
• Regulation of Mitogen-Activated Protein Kinases by Sphingolipid Products in Oligodendrocytes

  1999cited by this paper
• Sphingosine 1-phosphate induces expression of early growth response-1 and fibroblast growth factor-2 through mechanism involving extracellular signal-regulated kinase in astroglial cells.

  1999cited by this paper
• EDG1 Is a Functional Sphingosine-1-phosphate Receptor That Is Linked via a Gi/o to Multiple Signaling Pathways, Including Phospholipase C Activation, Ca2+Mobilization, Ras-Mitogen-activated Protein Kinase Activation, and Adenylate Cyclase Inhibition*

  1998cited by this paper
• Ceramide Inhibits Inwardly Rectifying K+ Currents via a Ras- and Raf-1-Dependent Pathway in Cultured Oligodendrocytes

  1998cited by this paper
• Sphingosine-1-phosphate as a ligand for the G protein-coupled receptor EDG-1.

  1998cited by this paper
• FTY720, a novel immunosuppressant, induces sequestration of circulating mature lymphocytes by acceleration of lymphocyte homing in rats. I. FTY720 selectively decreases the number of circulating mature lymphocytes by acceleration of lymphocyte homing.

  1998cited by this paper
• Role of Extracellular Signal‐Regulated Protein Kinases 1 and 2 in Oligodendroglial Process Extension

  1997cited by this paper
• Endogenous progenitors remyelinate demyelinated axons in the adult CNS.

  1997cited by this paper
• Activation of Mitogen‐Activated Protein Kinases in Oligodendrocytes

  1996cited by this paper
• Differential effects of the Rac GTPase on Purkinje cell axons and dendritic trunks and spines

  1996cited by this paper
• Distinct effects of bFGF and PDGF on oligodendrocyte progenitor cells

  1993cited by this paper
• Multiple extracellular signals are required for long-term oligodendrocyte survival.

  1993cited by this paper
• Type 1 astrocytes and oligodendrocyte‐type 2 astrocyte glial progenitors migrate toward distinct molecules

  1990cited by this paper
• PDGF and intracellular signaling in the timing of oligodendrocyte differentiation

  1989cited by this paper
• Preparation of separate astroglial and oligodendroglial cell cultures from rat cerebral tissue

  1980cited by this paper

• Cytokine Gene Expression and Treatment Impact on MRI Outcomes in Jordanian Patients with Multiple Sclerosis

  2025cites this paper
• Demyelination and Remyelination: General Principles.

  2025cites this paper
• The Effects of the S1P Receptor Agonist Fingolimod (FTY720) on Central and Peripheral Myelin in Twitcher Mice

  2024cites this paper
• Siponimod Attenuates Neuronal Cell Death Triggered by Neuroinflammation via NFκB and Mitochondrial Pathways

  2024cites this paper
• Astrocytic TIMP-1 regulates production of Anastellin, an inhibitor of oligodendrocyte differentiation and FTY720 responses

  2024cites this paper
• Deciphering the role of sphingosine 1‐phosphate in central nervous system myelination and repair

  2024cites this paper
• Astrocytic TIMP-1 regulates production of Anastellin, a novel inhibitor of oligodendrocyte differentiation and FTY720 responses

  2023cites this paper
• Molecular and neuroimmune pharmacology of S1P receptor modulators and other disease-modifying therapies for multiple sclerosis.

  2023cites this paper
• Immune System and Brain/Intestinal Barrier Functions in Psychiatric Diseases: Is Sphingosine-1-Phosphate at the Helm?

  2023cites this paper
• Locomotor and histological changes in a cuprizone-induced animal model of multiple sclerosis: comparison between alpha-tocopherol and fingolimod

  2022cites this paper
• Visualizing Sphingosine-1-Phosphate Receptor 1(S1P_1) Signaling During Central Nervous System De- and Remyelination

  2022cites this paper
• Fingolimod mitigates synaptic deficits and psychosis‐like behavior in APP/PSEN1 mice

  2022cites this paper
• Oscillatory calcium release and sustained store-operated oscillatory calcium signaling prevents differentiation of human oligodendrocyte progenitor cells

  2021cites this paper
• Neuronal contact upregulates astrocytic sphingosine‐1‐phosphate receptor 1 to coordinate astrocyte‐neuron cross communication

  2021cites this paper
• The Role of Sphingosine-1-Phosphate in Neurodegenerative Diseases

  2021cites this paper
• Visualizing Sphingosine-1-Phosphate Receptor 1(S1P1) Signaling During Central Nervous System De- and Re-Myelination

  2021cites this paper
• The impact of translational research on the development of therapeutic agents for multiple sclerosis

  2021cites this paper
• Lipid rafts as platforms for sphingosine 1-phosphate metabolism and signalling.

  2021cites this paper
• New Insight into the Role of Adenosine in Demyelination, Stroke and Neuropathic Pain

  2021influential citation
• Sphingosine kinase 2 is essential for remyelination following cuprizone intoxication

  2021cites this paper
• A2B Adenosine Receptors and Sphingosine 1-Phosphate Signaling Cross-Talk in Oligodendrogliogenesis

  2021influential citation
• Translational Characterization of the Glia Role in Multiple Sclerosis

  2021cites this paper
• Lessons from S1P receptor targeting in multiple sclerosis.

  2021cites this paper
• Signaling through the S1P−S1PR Axis in the Gut, the Immune and the Central Nervous System in Multiple Sclerosis: Implication for Pathogenesis and Treatment

  2021cites this paper
• Lysophospholipids and Their G-Coupled Protein Signaling in Alzheimer’s Disease: From Physiological Performance to Pathological Impairment

  2020cites this paper
• The particle size of drug nanocarriers dictates the fate of neurons; critical points in neurological therapeutics

  2020cites this paper
• Sphingosine-1-Phosphate Receptor Modulators and Oligodendroglial Cells: Beyond Immunomodulation

  2020cites this paper
• Effects of fingolimod, a sphingosine-1-phosphate (S1P) receptor agonist, on white matter microstructure, cognition and symptoms in schizophrenia

  2020cites this paper
• Adenosine A2B receptors inhibit K+ currents and cell differentiation in cultured oligodendrocyte precursor cells and modulate sphingosine-1-phosphate signaling pathway.

  2020cites this paper
• The role of Sphingolipids in myelination and myelin stability and their involvement in childhood and adult demyelinating disorders

  2020cites this paper
• Sphingosine-1-Phosphate: Its Pharmacological Regulation and the Treatment of Multiple Sclerosis: A Review Article

  2020cites this paper
• Fingolimod after a first unilateral episode of acute optic neuritis (MOVING) – preliminary results from a randomized, rater-blind, active-controlled, phase 2 trial

  2020cites this paper
• Possible regenerative effects of fingolimod (FTY720) in multiple sclerosis disease: An overview on remyelination process

  2020influential citation
• Fingolimod Rescues Demyelination in a Mouse Model of Krabbe's Disease

  2020cites this paper
• Does Siponimod Exert Direct Effects in the Central Nervous System?

  2020cites this paper
• Mechanism of action of s1p receptor modulators in multiple sclerosis: The double requirement.

  2019cites this paper
• Combination Therapy With Fingolimod and Neural Stem Cells Promotes Functional Myelination in vivo Through a Non-immunomodulatory Mechanism

  2019cites this paper
• Fingolimod: Lessons Learned and New Opportunities for Treating Multiple Sclerosis and Other Disorders.

  2019cites this paper
• Pleotropic Roles of Autotaxin in the Nervous System Present Opportunities for the Development of Novel Therapeutics for Neurological Diseases

  2019cites this paper
• Effect of fingolimod on oligodendrocyte maturation under prolonged cerebral hypoperfusion.

  2019cites this paper
• Immunology of oligodendrocyte precursor cells in vivo and in vitro.

  2019cites this paper
• Current advancements in promoting remyelination in multiple sclerosis

  2018cites this paper
• Sphingosine 1-Phosphate Receptor Subtype 1 as a Therapeutic Target for Brain Trauma

  2018cites this paper
• Sphingolipids in neurodegeneration (with focus on ceramide and S1P).

  2018cites this paper
• Potential neuroprotective effect of Fingolimod in multiple sclerosis and its association with clinical variables

  2018cites this paper
• 2 Bioactive Lipids in Stem Cell Differentiation

  2018cites this paper
• Fingolimod reduces the clinical expression of active demyelinating lesions in MS.

  2018cites this paper
• Effect of Fingolimod on Neural Stem Cells: A Novel Mechanism and Broadened Application for Neural Repair.

  2017cites this paper
• The Sphingosine 1-Phosphate Signaling Pathway in Epilepsy: A Possible Role for the Immunomodulator Drug Fingolimod in Epilepsy Treatment.

  2017cites this paper
• Mapping Protein Targets of Bioactive Small Molecules Using Lipid-Based Chemical Proteomics.

  2017cites this paper
• FTY720 (Fingolimod) reverses &agr;‐synuclein‐induced downregulation of brain‐derived neurotrophic factor mRNA in OLN‐93 oligodendroglial cells

  2017cites this paper
• Crosstalk between sphingolipids and vitamin D3: potential role in the nervous system

  2017cites this paper
• Role of Oligodendrocyte Dysfunction in Demyelination, Remyelination and Neurodegeneration in Multiple Sclerosis.

  2017cites this paper
• Synergistic protective effect of FTY720 and vitamin E against simulated cerebral ischemia in vitro.

  2017cites this paper
• The sphingosine-1-phosphate receptor: A novel therapeutic target for multiple sclerosis and other autoimmune diseases.

  2017cites this paper
• Multipotency and therapeutic potential of NG2 cells.

  2017cites this paper
• Effects of FTY720 on brain neurogenic niches in vitro and after kainic acid-induced injury

  2017cites this paper
• Morphogenetic Sphingolipids in Stem Cell Differentiation and Embryo Development

  2017cites this paper
• Lipidomics of Stem Cells

  2017cites this paper
• Beyond Clotting: A Role of Platelets in CNS Repair?

  2016cites this paper
• Fingolimod protects against neonatal white matter damage and long-term cognitive deficits caused by hyperoxia.

  2016cites this paper
• Therapeutic Potential of the Modulation of Sphingosine-1-Phosphate Receptors.

  2016cites this paper
• Fingolimod modulates multiple neuroinflammatory markers in a mouse model of Alzheimer’s disease

  2016cites this paper
• The dual S1PR1/S1PR5 drug BAF312 (Siponimod) attenuates demyelination in organotypic slice cultures

  2016cites this paper
• Sphingosine kinase inhibition ameliorates chronic hypoperfusion-induced white matter lesions.

  2016cites this paper
• Extracellular cues influencing oligodendrocyte differentiation and (re)myelination.

  2016influential citation
• S1P1 deletion in oligodendroglial lineage cells: Effect on differentiation and myelination

  2016cites this paper
• In vitro and ex vivo models of multiple sclerosis.

  2016cites this paper
• Integrated sphingosine-1 phosphate signaling in the central nervous system: From physiological equilibrium to pathological damage.

  2016cites this paper
• Multimodal evoked potentials follow up in multiple sclerosis patients under fingolimod therapy.

  2016cites this paper
• Cell Injury , Repair , Aging and Apoptosis Fingolimod ( FTY 720 ) Enhances Remyelination Following Demyelination of Organotypic Cerebellar Slices

  2016cites this paper
• Molecular Mechanism Underlying PD Pathogenesis-A Possible Role for Sphingosine Kinases and Sphingosine-1-Phosphate

  2015cites this paper
• Promoting remyelination in multiple sclerosis: Current drugs and future prospects

  2015cites this paper
• The sphingosine 1‐phosphate receptor agonist FTY720 is neuroprotective after cuprizone‐induced CNS demyelination

  2015cites this paper
• Regulation of human glia by multiple sclerosis disease modifying therapies

  2015cites this paper
• Multiple sclerosis—a quiet revolution

  2015cites this paper
• Galactosylsphingosine (psychosine)-induced demyelination is attenuated by sphingosine 1-phosphate signalling

  2015cites this paper
• Inflammatory responses in brain ischemia.

  2015cites this paper
• Fingolimod (FTY720) enhances hippocampal synaptic plasticity and memory in Huntington's disease by preventing p75NTR up-regulation and astrocyte-mediated inflammation.

  2015cites this paper
• Activation of S1P1 Receptor Regulates PI3K/Akt/FoxO3a Pathway in Response to Oxidative Stress in PC12 Cells

  2015cites this paper
• Fingolimod induces the transition to a nerve regeneration promoting Schwann cell phenotype.

  2015cites this paper
• Sphingosine 1-phosphate signaling pathway in inner ear biology. New therapeutic strategies for hearing loss?

  2015cites this paper
• Transforming growth factor β2 (TGF-β2)-induced connective tissue growth factor (CTGF) expression requires sphingosine 1-phosphate receptor 5 (S1P5) in human mesangial cells.

  2015cites this paper
• Fingolimod treatment promotes proliferation and differentiation of oligodendrocyte progenitor cells in mice with experimental autoimmune encephalomyelitis.

  2015cites this paper
• Molecular pharmacodynamics of new oral drugs used in the treatment of multiple sclerosis

  2014cites this paper
• Innate inflammatory responses in stroke: mechanisms and potential therapeutic targets.

  2014cites this paper
• Overview and safety of fingolimod hydrochloride use in patients with multiple sclerosis

  2014cites this paper
• Central effects of fingolimod.

  2014cites this paper
• Sphingosine-1-Phosphate Signaling in Immunology and Infectious Diseases

  2014cites this paper
• Efectos del fingolimod en el sistema nervioso central

  2014cites this paper
• Mechanisms of action of fingolimod in multiple sclerosis

  2014cites this paper
• Role of p38MAPK in S1P receptor‐mediated differentiation of human oligodendrocyte progenitors

  2014cites this paper
• Sphingosine-1 phosphate and central nervous system.

  2014cites this paper
• Oligodendrogenesis in the normal and pathological central nervous system

  2014cites this paper
• Systematic Review and Meta-Analysis of the Efficacy of Sphingosine-1-Phosphate (S1P) Receptor Agonist FTY720 (Fingolimod) in Animal Models of Stroke

  2013cites this paper
• A Review of the Role of Sphingosine-1-Phosphate in the Brain: An Important Mediator Implicated in the Central Nervous System

  2013cites this paper
• Protective Effect of FTY720 Against Sevoflurane-Induced Developmental Neurotoxicity in Rats

  2013cites this paper
• Role of Sphingosine 1-Phosphate (S1P) Receptor 1 in Experimental Autoimmune Encephalomyelitis —I

  2013cites this paper
• Sphingolipids in cardiovascular and cerebrovascular systems: Pathological implications and potential therapeutic targets.

  2013cites this paper
• Sphingosine 1-phosphate receptor agonists: a patent review (2010 – 2012)

  2013cites this paper